Procainamide in plasma following administration of sustained-release tablets in acute myocardial infarction.
作者信息
Ihlen H, Skomedal T, Stafsnes H, Ditlefsen E M
出版信息
Curr Ther Res Clin Exp. 1975 Mar;17(3):257-62.
PMID:805020
Abstract
摘要
相似文献
1
Procainamide in plasma following administration of sustained-release tablets in acute myocardial infarction.
Curr Ther Res Clin Exp. 1975 Mar;17(3):257-62.
2
[Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
Ugeskr Laeger. 1976 Sep 27;138(40):2433-7.
3
Procainamide in acute myocardial infarction: a study on two different tablet preparations of sustained release type.
Curr Ther Res Clin Exp. 1975 Nov;18(5):720-6.
4
5
Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
Eur J Clin Pharmacol. 1973 Dec;6(4):245-50. doi: 10.1007/BF00644740.
6
Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.急性心肌梗死中使用普鲁卡因胺进行抗心律失常预防。
N Engl J Med. 1969 Dec 4;281(23):1253-60. doi: 10.1056/NEJM196912042812301.
7
Experiences on a sustained-release procainamide preparation.关于一种普鲁卡因胺缓释制剂的经验。
Curr Ther Res Clin Exp. 1973 Oct;15(10):707-12.
8
Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
Can J Cardiol. 1990 Jan-Feb;6(1):15-8.
9
Sustained release procainamide in patients with myocardial infarction.心肌梗死患者使用缓释普鲁卡因酰胺。
Br Heart J. 1976 Jan;38(1):77-80. doi: 10.1136/hrt.38.1.77.
10
Ventricular ectopy.
J Fam Pract. 1984 Dec;19(6):731-3, 737, 741-2 passim.
Zotero 插件